Taysha Gene Therapies stock price target raised to $10 by BofA on trial data

Markets Investing.com By Investing.com 22 Jun 2026 17:14 1 min read

Taysha Gene Therapies stock price target raised to $10 by BofA on trial data

Taysha Gene Therapies stock price target raised to $10 by BofA on trial data

Taysha Gene Therapies stock price target raised to $10 by BofA on trial data

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.